Mikael L Rinne, Patrick Y Wen. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antineoplastic Agents, Alkylating/adverse effectsAntineoplastic Agents, Alkylating/therapeutic useAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useChemotherapy, AdjuvantDacarbazine/adverse effectsDacarbazine/analogs & derivativesDacarbazine/therapeutic useEvidence-Based MedicineGlioma/drug therapyGlioma/pathologyHumansLomustine/administration & dosageNeoplasm GradingNeoplasm StagingOligodendroglioma/drug therapyOligodendroglioma/mortalityOligodendroglioma/pathologyProcarbazine/administration & dosagePrognosisRadiotherapy, AdjuvantRandomized Controlled Trials as TopicSurvival AnalysisTemozolomideTreatment OutcomeVincristine/administration & dosage
Substances： See more » Antineoplastic Agents, AlkylatingProcarbazineVincristineLomustineDacarbazineTemozolomide
Year: 2015 PMID： 25952491
Source DB: PubMed Journal: Oncology (Williston Park) ISSN： 0890-9091 Impact factor: 2.990